The antibody–drug conjugate SHR-A1904 for targeting CLDN18.2 in advanced gastric or gastroesophageal junction cancer: a phase 1 trial

作者：Dan‐Yun Ruan, Hao‐Xiang Wu, Suxia Luo, Wenwen Huang, Xinjun Liang, Zuo-Xing Niu, Qi Dang, Hongli Li, Zhanyu Pan, Hongxia Lu, Yanqiao Zhang, Xingya Li, Xiuying Xiao, Shirong Cai, Yugang Dong, Jian Zhang, Li Zhou, Haitao Lan, Xin Wang, Ying Zhou, Rui Li, Heli Liu, Ping-Sheng Xu, Aili Suo, Ruinuo Jia, Yong-Qiang Li, Xiaodong Peng, Si-Chen Wang, Aihong Yu, Jie Xie, Miao‐Zhen Qiu, Rui‐Hua Xu · 发表于：Nature Medicine · 年份：2025 · DOI：10.1038/s41591-025-03781-w · 被引用次数：21 · 研究领域：Gastric Cancer Management and Outcomes、Gastrointestinal Tumor Research and Treatment、HER2/EGFR in Cancer Research